530313 — Kimia Biosciences Balance Sheet
0.000.00%
- IN₹3.23bn
- IN₹3.61bn
- IN₹1.19bn
- 76
- 24
- 81
- 67
Annual balance sheet for Kimia Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 11.8 | 15.8 | 2.41 | 1.48 | 17.4 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 425 | 310 | 328 | 290 | 374 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 718 | 731 | 827 | 614 | 753 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 340 | 351 | 342 | 324 | 309 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1,067 | 1,095 | 1,213 | 1,000 | 1,112 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 509 | 618 | 764 | 694 | 818 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 882 | 946 | 1,159 | 996 | 1,012 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 184 | 149 | 54.6 | 3.31 | 99.7 |
Total Liabilities & Shareholders' Equity | 1,067 | 1,095 | 1,213 | 1,000 | 1,112 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |